Clinical Trial Update: Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older [Phase 1]

View source ↗

Summary

This is a Phase 1 safety study update for the Pneumococcal 13-valent Conjugate Vaccine in healthy people aged 2 months and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Pneumococcal Disease
• Pneumococcal Pneumonia

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Pneumococcal 13-valent Conjugate Vaccine | Phase 1 | Status: UNKNOWN